NCT06895681View on ClinicalTrials.gov

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

Not yet recruitingOBSERVATIONAL
Enrollment

50,000

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions
Solid TumorSolid Tumor, AdultSomatic MutationSolid Tumor, Unspecified, AdultHereditary Cancer
Interventions
PROCEDURE

Blood Sample

Obtained at the time of non-study related routine blood draw.

PROCEDURE

Tissue Sample

Obtained at the time of non-study related routine biopsy or surgical procedure.

PROCEDURE

Excess fluid Sample

Obtained at the time of non-study related routine biopsy, surgical procedure, paracentesis, or thoracentesis procedure.

OTHER

Medical Chart Review

Demographic, clinical, and pathologic information will be extracted from the medical record

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER